Blackstone Life Sciences raises money to invest in late-stage therapies that might otherwise languish. The group’s 43 employees include Barry Gertz, former head of global clinical development at Merck (MRK), and Paris Panayiotopoulos, a former CEO of Ariad Pharmaceuticals.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.